Cart
sales@molnova.com
Home - Products - Others - Other Targets - Quercetin 3-O-β-D-galactosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucoside

Quercetin 3-O-β-D-galactosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucoside

CAS No. ———

Quercetin 3-O-β-D-galactosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucoside( ——— )

Catalog No. M38441 CAS No. ———

Quercetin 3-O-β-D-galactosyl-(1→2)-α-L-rhamnosyl-7-O-β-D-glucoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Quercetin 3-O-β-D-galactosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Quercetin 3-O-β-D-galactosyl-(1→2)-α-L-rhamnosyl-7-O-β-D-glucoside
  • Description
    Quercetin 3-O-β-D-galactosyl-(1→2)-α-L-rhamnosyl-7-O-β-D-glucoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Disitamab

    Disitamab Vedotin (RC48-0) is a humanized monoclonal antibody that targets HER2 and can be utilized in creating antibody-drug conjugates (ADCs), specifically referred to as Disitamab Vedotin .

  • PDD00017273

    PDD00017273 is a radiosensitizing PARG) inhibitor with antitumor or activity for the study of epithelial ovaries.

  • BMS-P5 free base

    BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor.?BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.

Sign In Join Free